Cost-Effectiveness Of Ranibizumab Versus Laser In The Treatment Of Visual Impairment Due To Diabetic Macular Oedema (Dme) From The Colombian Health Care System Perspective
May 1, 2014, 00:00
10.1016/j.jval.2014.03.1667
https://www.valueinhealthjournal.com/article/S1098-3015(14)01718-5/fulltext
Title :
Cost-Effectiveness Of Ranibizumab Versus Laser In The Treatment Of Visual Impairment Due To Diabetic Macular Oedema (Dme) From The Colombian Health Care System Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01718-5&doi=10.1016/j.jval.2014.03.1667
First page :
A286
Section Title :
Sensory Systems Disorders
Open access? :
No
Section Order :
1153